COMPANY PROFILE / #3047
Andromeda Surgical
San Francisco, CAVenture Capital-Backed
OVERVIEW
Developer of AI-guided surgical navigation and robotic surgery technology designed to improve precision, efficiency, and outcomes in minimally invasive procedures. The company develops software-first surgical platforms, spatial navigation systems, autonomous surgery technologies, and robotic-assisted solutions that provide GPS-like guidance through human anatomy, enabling surgeons to perform complex procedures with greater accuracy and paving the way for surgeon-in-the-loop autonomous surgical capabilities.
已融资21.35
最新估值59.56
员工数16
成立年份2023
公司概况
- Companies
- Andromeda Surgical
- Description
- Developer of AI-guided surgical navigation and robotic surgery technology designed to improve precision, efficiency, and outcomes in minimally invasive procedures. The company develops software-first surgical platforms, spatial navigation systems, autonomous surgery technologies, and robotic-assisted solutions that provide GPS-like guidance through human anatomy, enabling surgeons to perform complex procedures with greater accuracy and paving the way for surgeon-in-the-loop autonomous surgical capabilities.
- Website
- www.andromedasurgical.com
- HQ Location
- San Francisco, CA
- Year Founded
- 2023
- Keywords
- automation ai, equipment manufacturing, medical devices, medical equipment, medical robotics, robotic device, surgical robotics
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 21.35
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 04-Aug-2026
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 15.06
- Last Financing Valuation
- 59.56
- Last Financing Status
- Completed
- Last Known Valuation
- 59.56
- Last Known Valuation Date
- 04-Aug-2026
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 63.00
- Valuation Estimate Growth Rate
- 5.79%
- Active Investors
- 468 Capital, Alumni Ventures, BBQ Capital, CoreNest Capital, Cybernetix Ventures, Device of Tomorrow Capital, Earl Grey Capital, Hatcher+, Johnson & Johnson Innovation - JLABS, Julian Capital, Lingotto, Mana Ventures, North South Ventures, NZVC, Orange Collective, Phaze Ventures, Pioneer Fund, Rebel Fund, Roar Ventures, Standard Capital (California), StartX (US), Vox Capital, WestWave Capital, Y Combinator, Zelda Ventures, Zeno Ventures
- # Active Investors
- 26
- Acquirers
- —
团队与联系人
- Employees
- 16
- Employee Growth %
- 45.45% E
- Employee History
- 2026: 16, 2025: 11 E, 2024: 6, 2023: 1
- Primary Contact
- Nicholas Damiano
- Primary Contact Title
- Co-Founder & Chief Executive Officer
- Primary Contact Email
- nick@andromedasurgical.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- 1.50
- Revenue Growth %
- —
- Growth Rate
- 1.34%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 98
- Size Multiple
- 3.90x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 78
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- 668
- SimilarWeb Unique Visitors Change
- 29
- SimilarWeb Growth Rate
- 0.00%
- SimilarWeb Growth Rate Percentile
- 9
- Success Probability Over Time – 1 Year
- 1%
- Success Probability Over Time – 3 Year
- 8%
- Success Probability Over Time – 5 Year
- 23%
记录来源：public.companies · 原始序号 #3047 · 所有字段均按数据库原值展示。